The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
Authors
Keywords
-
Journal
CIRCULATION
Volume 141, Issue 20, Pages 1600-1607
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-03-29
DOI
10.1161/circulationaha.120.046397
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial
- (2019) Nicholas A. Marston et al. CIRCULATION
- Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease
- (2019) Derek Klarin et al. NATURE GENETICS
- Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials
- (2018) Francesco Zaccardi et al. ATHEROSCLEROSIS
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies
- (2017) Setor K. Kunutsor et al. EUROPEAN HEART JOURNAL
- Lipid levels and risk of venous thrombosis: results from the MEGA-study
- (2017) Vânia M. Morelli et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature
- (2017) Vera Gessi et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) Deficiency is Protective Against Venous Thrombosis in Mice
- (2017) Hui Wang et al. Scientific Reports
- Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis
- (2017) Setor K Kunutsor et al. Lancet Haematology
- Venous thromboembolism has the same risk factors as atherosclerosis
- (2016) Yuhong Mi et al. MEDICINE
- Next-generation genotype imputation service and methods
- (2016) Sayantan Das et al. NATURE GENETICS
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- Second-generation PLINK: rising to the challenge of larger and richer datasets
- (2015) Christopher C Chang et al. GigaScience
- Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis
- (2012) Pia R. Kamstrup et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism
- (2012) Anna Helgadottir et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipid levels do not influence the risk of venous thromboembolism
- (2012) I. M. van Schouwenburg et al. THROMBOSIS AND HAEMOSTASIS
- Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials
- (2012) Kazem Rahimi et al. PLOS MEDICINE
- Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism
- (2011) Aurélien Delluc et al. ATHEROSCLEROSIS
- Risk Factors for Venous Thromboembolism
- (2010) Anders G. Holst et al. CIRCULATION
- Fast model-based estimation of ancestry in unrelated individuals
- (2009) D. H. Alexander et al. GENOME RESEARCH
- Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women
- (2009) B. M. EVERETT et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
- (2009) Robert J. Glynn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More